These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 27670695)

  • 1. The role of Dickkopf-1 in joint remodeling and fibrosis: A link connecting spondyloarthropathies and scleroderma?
    Klavdianou K; Liossis SN; Sakkas L; Daoussis D
    Semin Arthritis Rheum; 2017 Feb; 46(4):430-438. PubMed ID: 27670695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dkk1: A key molecule in joint remodelling and fibrosis.
    Klavdianou K; Liossis SN; Daoussis D
    Mediterr J Rheumatol; 2017 Dec; 28(4):174-182. PubMed ID: 32185280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The emerging role of Dickkopf-1 in bone biology: is it the main switch controlling bone and joint remodeling?
    Daoussis D; Andonopoulos AP
    Semin Arthritis Rheum; 2011 Oct; 41(2):170-7. PubMed ID: 21435697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of dickkopf-1 enhances the proliferation and osteogenic potential of fibroblasts isolated from ankylosing spondylitis patients via the Wnt/β-catenin signaling pathway in vitro.
    Zou YC; Yang XW; Yuan SG; Zhang P; Ye YL; Li YK
    Connect Tissue Res; 2016 May; 57(3):200-11. PubMed ID: 26837533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B cell depletion therapy upregulates Dkk-1 skin expression in patients with systemic sclerosis: association with enhanced resolution of skin fibrosis.
    Daoussis D; Tsamandas A; Antonopoulos I; Filippopoulou A; Papachristou DJ; Papachristou NI; Andonopoulos AP; Liossis SN
    Arthritis Res Ther; 2016 May; 18(1):118. PubMed ID: 27208972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dickkopf-1 (Dkk-1) serum levels in systemic sclerosis and rheumatoid arthritis patients: correlation with the Trabecular Bone Score (TBS).
    Ruaro B; Casabella A; Paolino S; Pizzorni C; Ghio M; Seriolo C; Molfetta L; Odetti P; Smith V; Cutolo M
    Clin Rheumatol; 2018 Nov; 37(11):3057-3062. PubMed ID: 30291470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dickkopf-1 is downregulated early and universally in the skin of patients with systemic sclerosis despite normal circulating levels.
    Daoussis D; Papachristou DJ; Dimitroulas T; Sidiropoulos T; Antonopoulos I; Andonopoulos AP; Liossis SN
    Clin Exp Rheumatol; 2018; 36 Suppl 113(4):45-49. PubMed ID: 30277866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DKK-1 Is Underexpressed in Mesenchymal Stem Cells from Patients with Ankylosing Spondylitis and Further Downregulated by IL-17.
    Daoussis D; Kanellou A; Panagiotopoulos E; Papachristou D
    Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of blood bone turnover biomarkers and Wnt signaling antagonists with AS, DISH, OPLL, and OYL.
    Niu CC; Lin SS; Yuan LJ; Chen LH; Yang CY; Chung AN; Lu ML; Tsai TT; Lai PL; Chen WJ
    BMC Musculoskelet Disord; 2017 Feb; 18(1):61. PubMed ID: 28153008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wnt antagonist DKK-1 levels in systemic sclerosis are lower in skin but not in blood and are regulated by microRNA33a-3p.
    Henderson J; Pryzborski S; Stratton R; O'Reilly S
    Exp Dermatol; 2021 Jan; 30(1):162-168. PubMed ID: 32592422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wnt10b and Dkk-1 gene therapy differentially influenced trabecular bone architecture, soft tissue integrity, and osteophytosis in a skeletally mature rat model of osteoarthritis.
    Mason JB; Gurda BL; Hankenson KD; Harper LR; Carlson CS; Wilson JM; Richardson DW
    Connect Tissue Res; 2017 Nov; 58(6):542-552. PubMed ID: 27937051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence that Dkk-1 is dysfunctional in ankylosing spondylitis.
    Daoussis D; Liossis SN; Solomou EE; Tsanaktsi A; Bounia K; Karampetsou M; Yiannopoulos G; Andonopoulos AP
    Arthritis Rheum; 2010 Jan; 62(1):150-8. PubMed ID: 20039407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic studies on components of the Wnt signalling pathway and the severity of joint destruction in rheumatoid arthritis.
    de Rooy DP; Yeremenko NG; Wilson AG; Knevel R; Lindqvist E; Saxne T; Krabben A; Leijsma MK; Daha NA; Tsonaka S; Zhernakova A; Houwing-Duistermaat JJ; Huizinga TW; Toes RE; Baeten DL; Brouwer E; van der Helm-van Mil AH
    Ann Rheum Dis; 2013 May; 72(5):769-75. PubMed ID: 23041840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Diagnostic Value of Dkk-1 Level in Ankylosing Spondylitis: Comparison of Test Systems Based on Aptamers and Antibodies.
    Vorobyeva MA; Shatunova EA; Kolpakov KI; Kurochkina YD; Korolev MA
    Bull Exp Biol Med; 2022 Jul; 173(3):317-321. PubMed ID: 35852688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wnt pathway and IL-17: novel regulators of joint remodeling in rheumatic diseases. Looking beyond the RANK-RANKL-OPG axis.
    Daoussis D; Andonopoulos AP; Liossis SN
    Semin Arthritis Rheum; 2010 Apr; 39(5):369-83. PubMed ID: 19095294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone morphogenetic proteins and Dickkopf-1 in ankylosing spondylitis.
    Liao HT; Lin YF; Tsai CY; Chou TC
    Scand J Rheumatol; 2018 Jan; 47(1):56-61. PubMed ID: 28303752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dickkopf-1 in ankylosing spondylitis: Review and meta-analysis.
    Wu M; Chen M; Ma Y; Yang J; Han R; Yuan Y; Hu X; Wang M; Zhang X; Xu S; Liu R; Jiang G; Xu J; Shuai Z; Zou Y; Pan G; Pan F
    Clin Chim Acta; 2018 Jun; 481():177-183. PubMed ID: 29544750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of tumour necrosis factor-α inhibitor on serum level of dickkopf-1 protein and bone morphogenetic protein-7 in ankylosing spondylitis patients with high disease activity.
    Korkosz M; Gąsowski J; Leszczyński P; Pawlak-Buś K; Jeka S; Siedlar M; Grodzicki T
    Scand J Rheumatol; 2014; 43(1):43-8. PubMed ID: 24447112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging Role and Therapeutic Implication of Wnt Signaling Pathways in Autoimmune Diseases.
    Shi J; Chi S; Xue J; Yang J; Li F; Liu X
    J Immunol Res; 2016; 2016():9392132. PubMed ID: 27110577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor necrosis factor and interleukin-6 differentially regulate Dkk-1 in the inflamed arthritic joint.
    Yeremenko N; Zwerina K; Rigter G; Pots D; Fonseca JE; Zwerina J; Schett G; Baeten D
    Arthritis Rheumatol; 2015 May; 67(8):2071-5. PubMed ID: 25941031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.